SEC Form 4 · accession 0001127602-17-003784
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Melissa Lueke
Officer — Exec VP, CFO
Period of report
Feb 2, 2017
Accepted (ET)
Feb 3, 2017 · 10:21 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 2, 2017 | P | 4,000 | $12.5891 | A | 167,071 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Prices range from $12.5750 per share to $12.6000 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.